Author:
Koszałka Patrycja,Szmit Ewa,Myśliwski Andrzej,Bigda Jacek
Publisher
Springer Science and Business Media LLC
Subject
General Medicine,Immunology,Immunology and Allergy
Reference73 articles.
1. Abe Y., Sekiya S., Yamasita T. and Sendo F. (1990): Vascular hyperpermeability induced by tumor necrosis factor and its augmentation by IL-1 and IFN-α is inhibited by selective depletion of neutrophils with a monoclonal antibody. J. Immunol., 145, 2902–2907.
2. Aggarwal B. B. and Natarajan K. (1996): Tumor necrosis factors. Development during the last decade. Eur. Cytokine Netw., 7, 93–124.
3. Asami T., Imai M., Tanaka Y., Hosaka Y., Kato K., Nakamura N., Horisawa Y., Ashida Y., Kanamori T., Nobuhara M. and Kurimoto M. (1989): In vivo antitumor mechanism of natural human tumor necrosis factor involving a T cell-mediated immunological route. Jpn. J. Cancer Res., 80, 1161–1164.
4. Asher A. L., Mulé J. J. and Rosenberg S. A. (1989): Recombinant human tumor necrosis factor mediates regression of a murine sarcoma in vivo via Lyt-2+ cells. Cancer Immunol. Immunother., 28, 153–156.
5. Bachwich P. R., Chensue S. W., Larrick J. W. and Kunkel S. L. (1986): Tumor necrosis factor stimulates interleukin-1 and prostaglandin E2 production in resting macrophages. Biochem. Biophys. Res. Commun., 136, 94–101.
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献